|
165
|
---
|
A Randomized Comparision of Radiation Plus Weekly Cisplatin vs Radiation Plus PVI (Protracted Venous Infusion) 5-FU in Patients with stage II-B, III-B, and IV-A Carcinoma of the Cervix. - CLOSED
|
| | | |
|
191
|
---
|
A phase III Trial to Evaluate the Efficency of Maintaining Hemoglobin Levels Above 120 G/L with Erythropoietin versus above 100 G/L without Erythropoietin in Anemic Patients Receiving Concurrent Radiation and Cisplatin in Cervical Cancer. - CLOSED
|
| | | |
|
GOG-0249
|
---
|
A Phase III Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High Risk, Early Stage Endometrial Carcinoma ---CLOSED
|
|
GOG-0258
|
---
|
A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel For Optimally Debulked, Advanced Endometrial Carcinoma ---CLOSED(3/6/2015)
|
|
GOG-0274
|
---
|
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: THE OUTBACK TRIAL---CLOSED(6/1/2017)
|
|
GOG-0279
|
---
|
A Phase II Trial Evaluating Cisplatin (NSC #119875) and Gemcitabine (NSC #613327) Concurrent With Intensity-Modulated Radiation Therapy (IMRT) In The Treatment Of Locally Advanced Squamous Cell Carcinoma Of The Vulva--closure date of 2-20-2020
|
|
GOG-0238
|
---
|
A Randomized Trial of Pelvic Irradiation with or without Concurrent Weekly Cisplatin in Patients with Pelvic-only Recurrence of Carcinoma of the Uterine Corpus
--Closure date of 8/12/2020
|
| |
|
Link to Protocols
|
| |
|
|
| |
|
Note: If you need help with the protocol links, please contact the GOG Statistical Office (716 - 845 - 5702).
|